Log-in / Register

Not yet registered? Register Here.

Mortimer Sackler

Biography of Mortimer Sackler

Mortimer Sackler (seated)
Mortimer Sackler (seated)

Dr Mortimer Sackler (1916-2010) was an American physician and entrepreneur. He was Chairman and co-Chief Executive of Purdue Pharma, a leading American pharmaceuticals company. Alongside his brothers Arthur and Raymond, he used his fortune from the pharmaceutical industry to become a prominent philanthropist and he greatly supported the University of Glasgow.

Sackler was born on 7th December 1916 in Brooklyn to Isaac and Sophie (nee Greenberg), Polish Jewish immigrant Brooklyn grocers. After attending Erasmus Hall High School, Sackler sailed to the UK in 1937 and, with the help of Glasgow’s Jewish community, enrolled at Anderson’s College of Medicine, an institution that became part of the University of Glasgow in 1947. He attended the College between 1937-1939. His brothers Arthur and Raymond also studied at Anderson’s College in the years 1937-39 and 1938-40 respectively. Mortimer Sackler was prevented from finishing his degree at the University by the outbreak of the Second World War and finished his MD degree in Massachusetts. Dr Mortimer Sackler and his brothers bought the New York pharmaceuticals company Purdue Frederick Co in 1952. All three were research psychiatrists.

Mortimer Sackler received an honorary degree from the University of Glasgow in 2001 for his support of the University. He funded the Sackler Institute of Psychobiological Research, a research unit at the Southern General Hospital which investigates neuro-psychiatric disorders in association with the Sackler Institute at the University of Edinburgh. The Institute was opened in 2004.

Dr Mortimer Sackler died on 24th March 2010.

Summary

Mortimer Sackler
Born 7 December 1916.
Died 24 March 2010.
University Link: Benefactor, Honorary Graduate, Student
GU Degree:
Record last updated: 7th Feb 2017

University Connections

University Roles

  • Benefactor
  • Honorary Graduate
  • Student

There are no comments available. Log in using the box in the top right of the page to post a comment. No user account? Register here.